Nutra Pharma Corp. operates as a bio pharmaceutical company. The company is headquartered in Plantation, Florida and currently employs 4 full-time employees. The company went IPO on 2001-10-09. The firm's drug candidates include RPI-MN and RPI-78M. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin and Pet Pain-Away. Its pain relief categories include arthritis pain, chronic back pain, headaches and migraines, and knee and joint pain. Its over the counter (OTC) homeopathic products include Nyloxin Topical Gel, Extra Strength Nyloxin Topical Gel, Nyloxin Oral Spray, Extra Strength Nyloxin Oral Spray, Nyloxin Topical Gel Roll On, Nyloxin Professional Size Pump Topical Gel and Pet Pain Away. The firm holds approximately 21 patents in their portfolio.
How did NPHC's recent EPS compare to expectations?
The most recent EPS for Nutra Pharma Corp is $, expectations of $.
How did Nutra Pharma Corp NPHC's revenue perform in the last quarter?
Nutra Pharma Corp revenue for the last quarter is $
What is the revenue estimate for Nutra Pharma Corp?
According to of Wall street analyst, the revenue estimate of Nutra Pharma Corp range from $ to $
What's the earning quality score for Nutra Pharma Corp?
Nutra Pharma Corp has a earning quality score of A-/58.033184. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Nutra Pharma Corp report earnings?
Nutra Pharma Corp next earnings report is expected in 2023-02-19
What are Nutra Pharma Corp's expected earnings?
Nutra Pharma Corp expected earnings is $, according to wall-street analysts.
Did Nutra Pharma Corp beat earnings expectations?
Nutra Pharma Corp recent earnings of $ expectations.